1. Home
  2. DXCM vs RJF Comparison

DXCM vs RJF Comparison

Compare DXCM & RJF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DXCM
  • RJF
  • Stock Information
  • Founded
  • DXCM 1999
  • RJF 1962
  • Country
  • DXCM United States
  • RJF United States
  • Employees
  • DXCM N/A
  • RJF N/A
  • Industry
  • DXCM Medical/Dental Instruments
  • RJF Investment Bankers/Brokers/Service
  • Sector
  • DXCM Health Care
  • RJF Finance
  • Exchange
  • DXCM Nasdaq
  • RJF Nasdaq
  • Market Cap
  • DXCM 31.7B
  • RJF 31.4B
  • IPO Year
  • DXCM 2005
  • RJF N/A
  • Fundamental
  • Price
  • DXCM $60.02
  • RJF $156.32
  • Analyst Decision
  • DXCM Strong Buy
  • RJF Buy
  • Analyst Count
  • DXCM 20
  • RJF 12
  • Target Price
  • DXCM $88.20
  • RJF $181.00
  • AVG Volume (30 Days)
  • DXCM 8.2M
  • RJF 1.2M
  • Earning Date
  • DXCM 10-30-2025
  • RJF 10-22-2025
  • Dividend Yield
  • DXCM N/A
  • RJF 1.29%
  • EPS Growth
  • DXCM 7.75
  • RJF 6.19
  • EPS
  • DXCM 1.80
  • RJF 10.30
  • Revenue
  • DXCM $4,515,900,000.00
  • RJF $14,028,000,000.00
  • Revenue This Year
  • DXCM $17.43
  • RJF $11.86
  • Revenue Next Year
  • DXCM $13.22
  • RJF $7.82
  • P/E Ratio
  • DXCM $32.55
  • RJF $15.00
  • Revenue Growth
  • DXCM 14.21
  • RJF 9.62
  • 52 Week Low
  • DXCM $54.11
  • RJF $117.57
  • 52 Week High
  • DXCM $93.25
  • RJF $177.66
  • Technical
  • Relative Strength Index (RSI)
  • DXCM 43.00
  • RJF 40.57
  • Support Level
  • DXCM $57.20
  • RJF $156.75
  • Resistance Level
  • DXCM $60.85
  • RJF $167.94
  • Average True Range (ATR)
  • DXCM 2.52
  • RJF 3.35
  • MACD
  • DXCM 0.11
  • RJF -0.19
  • Stochastic Oscillator
  • DXCM 39.31
  • RJF 25.37

About DXCM DexCom Inc.

DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

About RJF Raymond James Financial Inc.

Raymond James Financial is a diversified financial services firm that provides wealth management, investment banking, asset management, and capital markets services to individuals, corporations, and municipalities. The firm maintains an extensive catalogue of products and services across its business lines. However, the wealth management franchise generates the bulk of its revenues and earnings through a vast network of nearly 8,800 independent and employee-affiliated advisors, who collectively manage over $1.7 trillion in client assets as of fiscal year-end 2025. While Raymond James maintains a global footprint, the company derives over 90% of its revenue, and an even larger percentage of its operating income, from the United States.

Share on Social Networks: